ASK PHARM released its performance for the first three quarters, with a net profit attributable to the parent company of 223 million yuan, a year-on-year increase of 75.81%

Zhitong
2025.10.28 10:39
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, ASK PHARM released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 1.434 billion yuan, a year-on-year increase of 3.57%. The net profit attributable to shareholders of the listed company was 223 million yuan, a year-on-year increase of 75.81%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 186 million yuan, a year-on-year increase of 81.89%

According to the Zhitong Finance APP, ASK PHARM (002755.SZ) released its third-quarter report for 2025. In the first three quarters, the company achieved an operating income of 1.434 billion yuan, a year-on-year increase of 3.57%. The net profit attributable to shareholders of the listed company was 223 million yuan, a year-on-year increase of 75.81%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 186 million yuan, a year-on-year increase of 81.89%

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.